Clinical Trials on Substance Dependence in New Zealand

Total 1262 results

Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Pemoline for Cocaine Abuse - 7

Cocaine-Related Disorders

United States
Yale University
VU University of Amsterdam

Completed

Tobacco Approach Avoidance Training for Adolescent Smokers-2 (AAT-2)

Tobacco Use Disorder

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Mobile Psychosocial Interventions for MMT Clients (MobileMMT)

Substance Abuse | Opioid Abuse

United States
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA)

Completed

Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color (YMHP-CBO)

Substance Use | Sexual Risk

United States
Yale University
University of Miami

Completed

Motivational Enhancement for Spanish Speaking Individuals - 1

Substance-Related Disorders

United States
New York State Psychiatric Institute
Clinilabs, Inc.

Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders

Cocaine-Related Disorders

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers

Tobacco Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Mazindol for Cocaine Abuse - 2

Cocaine-Related Disorders

United States
University of Rochester
National Cancer Institute (NCI); National Institutes of Health (NIH); New York... and other collaborators

Completed

Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence (SHP)

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)
US Department of Veterans Affairs

Completed

Alterations in Serotonergic Functions in Cocaine Addicts - 1

Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

Cannabis Use

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1

Tobacco Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effects of Aripiprazole on Cocaine Craving and Self-Administration

Cocaine Abuse

United States
Yale University

Recruiting

Prazosin for Alcohol Use Disorder With Withdrawal Symptoms

Alcohol Withdrawal

United States
Eunice Kennedy Shriver National Institute of Child...

Unknown

Pediatric Residency Training On Tobacco

Tobacco Use Disorder

United States
National Development and Research Institutes, Inc.
New York University; Rhode Island Hospital; Drexel University; Brandeis University

Recruiting

Overdose Risk Management and Naloxone

Opioid Use

United States
Columbia University
National Institute on Drug Abuse (NIDA)

Completed

Effects of Nicotine Replacement and Repeated Cue Exposure on Cigarette Craving

Tobacco Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users

Cannabis

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Treatment for Marijuana Addiction (MARINOL)

Marijuana Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2

Tobacco Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

Brain Imaging: Cocaine Effects & Medication Development - 5

Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals

Marijuana Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation

Tobacco Use Disorder

United States
VA Office of Research and Development

Completed

Cognitive Behavioral Therapy (CBT) for PTSD in Veterans With Co-Occurring SUDs (CBT)

PTSD | Substance Use Disorders

United States
Yale University

Completed

Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents (smokeScreen)

Smoking

United States
University of Pennsylvania

Completed

Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal (PGB-LOF)

Opioid Withdrawal

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Terminated

Lorcaserin for Cannabis Use Disorder

Cannabis Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Early Phase II Trials for Cocaine Medication Development - 1

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Pergolide Treatment for Substance Abusers - 4

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Substance-Related Disorders | Cocaine-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

Imaging the Neurochemistry of Drug Addiction With PET

Smoking | Cannabis

United States
University of New Mexico
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...

Terminated

Assessing the Fit of Motivational Interviewing by Cultures With Adolescents (AMICA)

Alcoholism

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Acamprosate Treatment: Mechanisms of Action

Alcoholism

United States
Yale University

Completed

Development of a Videogame Prototype Targeting Cigarette and Marijuana Smoking, and Tobacco Product Prevention Among Young Adolescents (smokeSCREEN)

Smoking

United States
Johns Hopkins University
Substance Abuse and Mental Health Services Administration (SAMHSA); Annie E... and other collaborators

Completed

Family Spirit Study

Substance Abuse

United States
University of Connecticut
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs (CHRP-BB)

Risk Behavior | HIV/AIDS | Medication Adherence | Substance Abuse

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

Women's Initiative Supporting Health Increasing Healthcare Access (WISH)

Substance-Related Disorders

United States
University of New Mexico
National Institute on Drug Abuse (NIDA)

Recruiting

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

Substance-Related Disorders | Treatment Adherence

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

Marijuana Abuse

United States
Dartmouth-Hitchcock Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Treatment for Adolescent Marijuana Abuse

Marijuana Abuse

United States
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA); Dartmouth College; Center for Health...

Completed

Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) (Seva)

HIV | Substance Use Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients

Cannabis Use Disorder

United States
NYU Langone Health
University of California, Los Angeles; Robert Wood Johnson Foundation

Completed

Financial Incentives for Smoking Treatment (FIESTA)

Smoking | Tobacco Use Disorder | Smoking, Tobacco

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Modeling Impaired Judgement in Cocaine Abusers - 6

Substance-Related Disorders | Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (AV411)

Opioid-Related Disorders

United States
New York State Psychiatric Institute

Completed

The Role of Neural Systems for Emotion Regulation in Coping With Alcohol Craving (FRAME)

Alcoholism

United States
University of California, Los Angeles
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

HIV | Substance Use | Mental Health | STI

United States

Clinical Trials on Substance Dependence in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations